
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current perspectives on inhibitory SMAD7 in health and disease
Charlotte de Ceuninck van Capelle, Maureen Spit, Peter ten Dijke
Critical Reviews in Biochemistry and Molecular Biology (2020) Vol. 55, Iss. 6, pp. 691-715
Open Access | Times Cited: 56
Charlotte de Ceuninck van Capelle, Maureen Spit, Peter ten Dijke
Critical Reviews in Biochemistry and Molecular Biology (2020) Vol. 55, Iss. 6, pp. 691-715
Open Access | Times Cited: 56
Showing 1-25 of 56 citing articles:
Targeting TGFβ signal transduction for cancer therapy
Sijia Liu, Jiang Ren, Peter ten Dijke
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 264
Sijia Liu, Jiang Ren, Peter ten Dijke
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 264
Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches
Innokenty A. Savin, Marina A. Zenkova, Aleksandra V. Sen’kova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14959-14959
Open Access | Times Cited: 120
Innokenty A. Savin, Marina A. Zenkova, Aleksandra V. Sen’kova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14959-14959
Open Access | Times Cited: 120
Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
Linshan Duan, Shu-Yu Cheng, Long Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 87
Linshan Duan, Shu-Yu Cheng, Long Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 87
Smad7 effects on TGF-β and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure
Claudio Humeres, Arti V. Shinde, Anis Hanna, et al.
Journal of Clinical Investigation (2021) Vol. 132, Iss. 3
Open Access | Times Cited: 86
Claudio Humeres, Arti V. Shinde, Anis Hanna, et al.
Journal of Clinical Investigation (2021) Vol. 132, Iss. 3
Open Access | Times Cited: 86
TGF-beta signal transduction: biology, function and therapy for diseases
Yan Tie, Fan Tang, Dandan Peng, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 65
Yan Tie, Fan Tang, Dandan Peng, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 65
Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
Jitske van den Bulk, Noel F.C.C. de Miranda, Peter ten Dijke
Clinical Science (2021) Vol. 135, Iss. 1, pp. 35-52
Open Access | Times Cited: 57
Jitske van den Bulk, Noel F.C.C. de Miranda, Peter ten Dijke
Clinical Science (2021) Vol. 135, Iss. 1, pp. 35-52
Open Access | Times Cited: 57
SMAD7 expression in CAR-T cells improves persistence and safety for solid tumors
Sixin Liang, Rui Zheng, Baile Zuo, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 3, pp. 213-226
Closed Access | Times Cited: 14
Sixin Liang, Rui Zheng, Baile Zuo, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 3, pp. 213-226
Closed Access | Times Cited: 14
Co‐Expression of Dominant‐Negative TGF ‐β Receptor 2 Enhances the Therapeutic Efficacy of Novel TREM1 /DAP12 ‐BB ‐Based CAR ‐T Cells in Solid Tumours
Shujia Zhu, Jianping Hu, Jie Lin, et al.
Immunology (2025)
Open Access | Times Cited: 1
Shujia Zhu, Jianping Hu, Jie Lin, et al.
Immunology (2025)
Open Access | Times Cited: 1
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Buel D. Rodgers, Christopher W. Ward
Endocrine Reviews (2021) Vol. 43, Iss. 2, pp. 329-365
Open Access | Times Cited: 53
Buel D. Rodgers, Christopher W. Ward
Endocrine Reviews (2021) Vol. 43, Iss. 2, pp. 329-365
Open Access | Times Cited: 53
To Ub or not to Ub: a regulatory question in TGF-β signaling
Jinquan Liu, Jianping Jin, Tingbo Liang, et al.
Trends in Biochemical Sciences (2022) Vol. 47, Iss. 12, pp. 1059-1072
Closed Access | Times Cited: 37
Jinquan Liu, Jianping Jin, Tingbo Liang, et al.
Trends in Biochemical Sciences (2022) Vol. 47, Iss. 12, pp. 1059-1072
Closed Access | Times Cited: 37
OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor
Chuannan Fan, Qian Wang, Gerard van der Zon, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 23
Chuannan Fan, Qian Wang, Gerard van der Zon, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 23
Signaling pathways underlying TGF-β mediated suppression of IL-12A gene expression in monocytes
Tetiana Hourani, Mahtab Eivazitork, Thivya Balendran, et al.
Molecular Immunology (2024) Vol. 166, pp. 101-109
Open Access | Times Cited: 5
Tetiana Hourani, Mahtab Eivazitork, Thivya Balendran, et al.
Molecular Immunology (2024) Vol. 166, pp. 101-109
Open Access | Times Cited: 5
Regenerative Therapy for Corneal Scarring Disorders
Christine Chandran, Mithun Santra, Elizabeth Rubin, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 649-649
Open Access | Times Cited: 5
Christine Chandran, Mithun Santra, Elizabeth Rubin, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 649-649
Open Access | Times Cited: 5
Epigenetic regulation of TGF-β pathway and its role in radiation response
Yunan Ding, Guangming Zhou, Wentao Hu
International Journal of Radiation Biology (2024) Vol. 100, Iss. 6, pp. 834-848
Closed Access | Times Cited: 5
Yunan Ding, Guangming Zhou, Wentao Hu
International Journal of Radiation Biology (2024) Vol. 100, Iss. 6, pp. 834-848
Closed Access | Times Cited: 5
Positive feedback loops between fibroblasts and the mechanical environment contribute to dermal fibrosis
Liang Zhu, Lechen Liu, Aoli Wang, et al.
Matrix Biology (2023) Vol. 121, pp. 1-21
Closed Access | Times Cited: 11
Liang Zhu, Lechen Liu, Aoli Wang, et al.
Matrix Biology (2023) Vol. 121, pp. 1-21
Closed Access | Times Cited: 11
Deletion of GPR81 activates CREB/Smad7 pathway and alleviates liver fibrosis in mice
Ying Zhi, Kerui Fan, Shuang Liu, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 4
Ying Zhi, Kerui Fan, Shuang Liu, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 4
JOSD2 inhibits angiotensin II-induced vascular remodeling by deubiquitinating and stabilizing SMAD7
Sirui Shen, Zhuqi Huang, Yukai Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Sirui Shen, Zhuqi Huang, Yukai Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
SMADS-Mediate Molecular Mechanisms in Sjögren’s Syndrome
Margherita Sisto, Doménico Ribatti, Sabrina Lisi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3203-3203
Open Access | Times Cited: 26
Margherita Sisto, Doménico Ribatti, Sabrina Lisi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3203-3203
Open Access | Times Cited: 26
PPARγ regulates the expression of genes involved in the DNA damage response in an inflamed endometrium
Karol Mierzejewski, Łukasz Paukszto, Aleksandra Kurzyńska, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Karol Mierzejewski, Łukasz Paukszto, Aleksandra Kurzyńska, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Unveiling the Impact of BMP9 in Liver Diseases: Insights into Pathogenesis and Therapeutic Potential
Han Chen, Ying-Yi Li, Kouki Nio, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1013-1013
Open Access | Times Cited: 3
Han Chen, Ying-Yi Li, Kouki Nio, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1013-1013
Open Access | Times Cited: 3
New Insights into AMPK, as a Potential Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatic Fibrosis
Hoon An, Yerin Jang, Jung-In Choi, et al.
Biomolecules & Therapeutics (2024)
Closed Access | Times Cited: 3
Hoon An, Yerin Jang, Jung-In Choi, et al.
Biomolecules & Therapeutics (2024)
Closed Access | Times Cited: 3
E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression
Abhishek Sinha, Prasanna Vasudevan Iyengar, Peter ten Dijke
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 476-476
Open Access | Times Cited: 22
Abhishek Sinha, Prasanna Vasudevan Iyengar, Peter ten Dijke
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 476-476
Open Access | Times Cited: 22
Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer
Jana Mašlanková, Ivana Večurkovská, Miroslava Rabajdová, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 33, pp. 4744-4761
Open Access | Times Cited: 14
Jana Mašlanková, Ivana Večurkovská, Miroslava Rabajdová, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 33, pp. 4744-4761
Open Access | Times Cited: 14
Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie’s Disease
Yozo Mitsui, Fumito Yamabe, Shunsuke Hori, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10133-10133
Open Access | Times Cited: 8
Yozo Mitsui, Fumito Yamabe, Shunsuke Hori, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10133-10133
Open Access | Times Cited: 8
A new approach to the preeclampsia puzzle; MicroRNA-326 in CD4+ lymphocytes might be as a potential suspect
Mohammad Ali Zolfaghari, Roza Motavalli, Mohammad Sadegh Soltani‐Zangbar, et al.
Journal of Reproductive Immunology (2021) Vol. 145, pp. 103317-103317
Closed Access | Times Cited: 19
Mohammad Ali Zolfaghari, Roza Motavalli, Mohammad Sadegh Soltani‐Zangbar, et al.
Journal of Reproductive Immunology (2021) Vol. 145, pp. 103317-103317
Closed Access | Times Cited: 19